AbstractColorectal cancer is the third most common malignancy in the United States. Improved detection sensitivity of early colorectal neoplasms would have important clinical applications. Herein, we report on using phage display to generate peptide libraries that detect colon carcinoma tissues. To accomplish this, we employed positive selection of a peptide-bearing phage library on poorly differentiated colon carcinoma cells (HT29) and combined this with negative selection of the phage library on well-differentiated colon carcinoma cells (HCT116). Analysis of the resulting library identified a nine-amino-acid, disulfide-constrained peptide, CPIEDRPMC (RPMreI), that stained HT29 colon carcinoma cells. Immunohistochemical staining using FITC...
Colorectal cancer (CRC) is a major cause of cancer-related deaths in much of the world. Most CRCs ar...
Hepatocellular carcinoma is the fourth leading cause of cancer death worldwide. Novel treatment stra...
Monoclonal antibodies have been successfully utilized as cancer-targeting therapeutics and diagnosti...
Colorectal cancer is the third most common malignancy in the United States. Improved detection sensi...
Colorectal cancer is the third most common malig-nancy in the United States. Improved detection sens...
AbstractColorectal cancer is the third most common malignancy in the United States. Improved detecti...
Tumor-targeting therapy can be an efficacious way to cure a malignant tumor in clinical trials. Phag...
Colorectal cancer is frequently diagnosed at an advanced stage due to the absence of early clinical ...
Colorectal cancer is frequently diagnosed at an advanced stage due to the absence of early clinical ...
Colorectal cancer is frequently diagnosed at an advanced stage due to the absence of early clinical ...
The development of intravascular conjugates that efficiently deliver genes or drugs to tumors is lim...
The development of intravascular conjugates that efficiently deliver genes or drugs to tumors is lim...
Colorectal cancer is frequently diagnosed at an advanced stage due to the absence of early clinical ...
Colorectal cancer is frequently diagnosed at an advanced stage due to the absence of early clinical ...
Background and Aim: Prostate cancer is one the most common causes of cancer-associated death in men....
Colorectal cancer (CRC) is a major cause of cancer-related deaths in much of the world. Most CRCs ar...
Hepatocellular carcinoma is the fourth leading cause of cancer death worldwide. Novel treatment stra...
Monoclonal antibodies have been successfully utilized as cancer-targeting therapeutics and diagnosti...
Colorectal cancer is the third most common malignancy in the United States. Improved detection sensi...
Colorectal cancer is the third most common malig-nancy in the United States. Improved detection sens...
AbstractColorectal cancer is the third most common malignancy in the United States. Improved detecti...
Tumor-targeting therapy can be an efficacious way to cure a malignant tumor in clinical trials. Phag...
Colorectal cancer is frequently diagnosed at an advanced stage due to the absence of early clinical ...
Colorectal cancer is frequently diagnosed at an advanced stage due to the absence of early clinical ...
Colorectal cancer is frequently diagnosed at an advanced stage due to the absence of early clinical ...
The development of intravascular conjugates that efficiently deliver genes or drugs to tumors is lim...
The development of intravascular conjugates that efficiently deliver genes or drugs to tumors is lim...
Colorectal cancer is frequently diagnosed at an advanced stage due to the absence of early clinical ...
Colorectal cancer is frequently diagnosed at an advanced stage due to the absence of early clinical ...
Background and Aim: Prostate cancer is one the most common causes of cancer-associated death in men....
Colorectal cancer (CRC) is a major cause of cancer-related deaths in much of the world. Most CRCs ar...
Hepatocellular carcinoma is the fourth leading cause of cancer death worldwide. Novel treatment stra...
Monoclonal antibodies have been successfully utilized as cancer-targeting therapeutics and diagnosti...